Perimenopause and Skin Changes: How Modulated EMS Fits a Hormonally-Shifting Routine
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
Perimenopause changes the skin in ways that catch many women off guard. A routine that has worked reliably for a decade can suddenly feel inadequate. The face that looked refreshed after a regular morning protocol can start looking flatter, less sculpted, more variable in puffiness. The reasons sit in the underlying hormonal shifts that are happening at the same time. Estrogen, progesterone, and the hormones that influence skin behavior all start fluctuating in patterns that affect the visible face daily.
Modulated EMS, including PureLift's contraction-relaxation cycling, fits into a perimenopausal routine as one of several supportive inputs. It does not address the hormonal changes directly. What it does is support the muscle activation, lymphatic flow, and microcirculation that the shifting hormonal environment can make less consistent on its own. This article walks through what changes in perimenopause from a skin and facial perspective, why those changes happen, and how a thoughtful PureLift routine integrates with the rest of the supportive interventions that women often layer during this phase.
What perimenopause actually means
Perimenopause is the transition phase leading up to menopause itself. It typically begins in the early forties for most women, though the exact timing varies widely, and it can last anywhere from four to ten years. During this window, the ovaries gradually reduce their estrogen and progesterone production, but the reduction is not linear. Hormone levels fluctuate, sometimes dramatically, before settling into the lower postmenopausal baseline. Menopause itself is technically defined as twelve consecutive months without a menstrual period.
The skin consequences of this transition are well documented. Estrogen plays multiple roles in skin biology, including supporting collagen production, maintaining skin hydration, and influencing the cyclical fluid balance that contributes to daily facial appearance. As estrogen declines and fluctuates, these supportive roles become less reliable, and the visible signature of the change starts showing up in the face.
The skin signature of the perimenopausal phase
Most women in perimenopause report a constellation of changes rather than a single dominant one. Skin thinning is one of the most common. The dermis loses about thirty percent of its collagen in the first five years after menopause, with much of that loss starting during the perimenopausal transition. The visible result is thinner-looking skin, more visible fine lines, and a loss of the resilience that younger skin had.
Volume changes are also common. The fat pads in the face redistribute and shrink in places, particularly the midface and the upper cheek, which contributes to the visible flattening that many women describe. The lower face, by contrast, can sometimes look heavier as the redistribution moves volume downward toward the jawline.
Variability in puffiness becomes more pronounced. The hormonal fluctuations of perimenopause affect daily fluid balance, and many women find that their morning face becomes more variable, more puffy on some days, more flat on others, in patterns that do not always match the obvious triggers like sleep or sodium.
Dryness intensifies. Sebaceous gland activity declines, the skin's ability to retain water decreases, and the routines that worked in the thirties and early forties often need adjustment toward more hydrating, less stripping ingredients.
Sleep disturbance often compounds all of this. Hot flashes, night sweats, and the broader sleep changes that perimenopause brings affect the overnight recovery the skin depends on. The morning face is doing less recovery than it used to, and the visible result is more cumulative day-to-day fatigue.
How modulated EMS supports the perimenopausal face
The visible changes of perimenopause have multiple drivers, and modulated EMS addresses some of them while leaving others to the upstream interventions where they belong. The supportive contributions PureLift offers fit into three categories.
The first is muscle-layer support. Cumulative tone-building from consistent contraction-relaxation cycling supports the resting position of the contour-defining muscles, which can partially offset the visible flattening that volume redistribution contributes to. The cumulative effect across four to eight weeks tends to show as a more defined jawline angle and a slightly more lifted cheek apple resting position than would otherwise be the perimenopausal baseline.
The second is lymphatic and circulation support. The contraction cycling supports lymphatic flow and microcirculation in the surrounding tissue. For users whose daily puffiness has become more variable, the immediate session-to-session depuffing effect provides a consistent input that can produce more reliable morning faces despite the underlying hormonal variability.
The third is routine. The act of doing a focused 10-minute self-care session, particularly during a phase of life where the body is undergoing significant change, has its own value. Many users describe the morning protocol as a small reliable input in a daily environment that has become less predictable, and the cumulative cosmetic effect adds up across weeks and months.
What works alongside modulated EMS in this phase
The supportive routine that pairs well with PureLift during perimenopause typically includes several elements. Daily sun protection is the most-leveraged single skincare input across this phase, because the underlying skin thinning makes UV damage register more visibly than it did at younger ages. Hydration-supportive ingredients in the skincare routine, including hyaluronic acid, ceramides, and gentle humectants, address the dryness that often intensifies. Topical actives appropriate for the phase, including retinoids used carefully and antioxidants in the morning routine, support skin quality over time.
Hormone replacement therapy, when prescribed and supervised by an appropriate provider, addresses the underlying hormonal driver of much of the visible change. This is a conversation for the user and her physician, and the decision sits well outside what any general article can advise on. For users on hormone therapy, the modulated EMS routine remains useful as a supportive cosmetic input, and integrates without conflict.
Adequate sleep is genuinely high-leverage during this phase, even when achieving it is harder. The overnight recovery the skin depends on responds to sleep quality more than to almost any topical intervention, and supporting sleep through whatever mechanisms work for the individual user has outsized cosmetic benefits.
Regular aerobic movement supports the general circulation that the skin's appearance depends on, and stress management, in whatever form works for the individual, helps moderate the sympathetic-driven facial changes that compound the visible effect of the hormonal shifts.
What modulated EMS does not address
The honest framing is that PureLift is one input in a routine that addresses a multi-factorial phase. It does not address the hormonal changes themselves. It does not reverse the collagen loss that has happened. It does not restore the fat-pad volume that redistribution has shifted. For these underlying changes, the appropriate interventions are dermatological, medical, or both, and the supervising providers' guidance takes priority.
What PureLift does is support the cosmetic-appearance contribution from muscle activation and circulation, which remains modifiable regardless of the hormonal background. The cumulative tone-building, the session-to-session depuffing, and the supported circulation are inputs that the perimenopausal face responds to in similar ways to younger skin, even though the underlying baseline may have shifted.
Realistic expectations across the transition
For users who integrate PureLift consistently across the perimenopausal phase, the visible outcomes tend to show as a more sculpted resting baseline than would otherwise be the case, more consistent morning faces despite the underlying daily variability, and the brighter complexion appearance that supported circulation contributes to. These outcomes are real and add up across the years of the transition.
The expectations worth setting are these. The face is undergoing real underlying change during perimenopause, and no cosmetic input fully prevents that change. What thoughtful inputs do is keep the visible outcome closer to the user's preferred baseline than it would otherwise be. PureLift fits into that frame as a consistent, supportive, daily contribution.
The bottom line
Perimenopause changes the skin in well-documented ways that span thinning, volume redistribution, increased puffiness variability, dryness, and the cumulative effect of disrupted sleep. Modulated EMS supports the muscle-layer activation, lymphatic flow, and microcirculation that contribute to the visible cosmetic outcome, fitting in as one input among several in a layered routine. It does not address the hormonal changes themselves, but it does support what remains modifiable through facial muscle work, and the cumulative effect across consistent use is meaningful for many women navigating this phase.
For more on the cumulative tone-building, see Why Lymphatic Drainage Is the Secret to a More Sculpted Face. For more on session-to-session expectations, see From Puffy to Sculpted.